|
We offer a range of
pharmaceutical bulk actives and intermediate in therapeutic
categories of Centralnervous system, Cardiovascular system,
Gastro-intestinal and Anti-infectives.
 |
Patent non-infringing
technologies
|
|
State-of-the-art pilot and commercial
scale multi-purpose
|
|
Pharmaceutical manufacturing plants
conforming to cGMP guidelines and approved by various regulatory
authorities such as US FDA, French AFSSAPS and Japanese PMDA.
|
|
R & D facilities to support early
development of generic APIs
|
|
High quality documents - Drug Master
Files |
We have more than 45 products
under different stages of development. The new product development
is mainly focused on therapeutic categories of Central Nervous
Systems, Cardiovascular system and Anti-diabetics. A dedicated team
of more than 100 research scientists work in our state-of-the-art
research centers at Noida and Nanjangud. These research facilities
are equipped with latest scientific instruments.
API Business:
Vision: To achieve global leadership in all major product
categories. |
Life
Science Ingredients
Ingredients (APIs)
